Understanding Blood Cancers: Leukemia, Lymphoma, and Myeloma

What are Blood Cancers? Blood cancers are a group of serious diseases that affect the blood, bone marrow, and lymphatic system. These cancers arise when abnormal blood cells grow uncontrollably, crowding out healthy cells and impairing the body's ability to function properly. September is recognized as Blood Cancer Awareness Month, a crucial time to shed light on these conditions, support those affected, and promote understanding and early detection. More than 1.5 million people in India and worldwide are currently living with or in remission from blood cancer. While advancements in treatment have significantly improved outcomes, blood cancers remain a significant health challenge, with a notable percentage of individuals facing survival challenges beyond five years post-diagnosis. Types of Blood Cancers The primary types of blood cancers include: Leukemia: This cancer originates in the blood-forming tissues, typically the bone marrow, and leads to the overproduction of abnormal white blood cells. These abnormal cells, known as leukemia cells, can't fight infection effectively and can crowd out normal white blood cells, red blood cells, and platelets. Leukemia can be broadly classified into acute (fast-growing) and chronic (slow-growing) forms, and further into lymphoid or myeloid types. Lymphoma: Lymphoma is a cancer of the lymphatic system, which is part of the body's germ-fighting network. The lymphatic system includes the lymph nodes, spleen, thymus gland, and bone marrow. Lymphoma starts when cells in the immune system called lymphocytes, a type of white blood cell, grow out of control. There are two main types: Hodgkin lymphoma and non-Hodgkin lymphoma, with many subtypes within each. Myeloma (Multiple Myeloma): Myeloma is a cancer that affects plasma cells, a type of white blood cell found in the bone marrow. Plasma cells normally produce antibodies that help fight infection. In myeloma, these plasma cells become cancerous (called myeloma cells) and multiply, crowding out healthy blood-forming cells in the bone marrow. This can lead to bone damage, kidney problems, and other complications. Symptoms of Blood Cancers The symptoms of blood cancers can vary depending on the type and how aggressive the cancer is. Some blood cancers, particularly chronic forms, may not show symptoms for many years. However, common signs and symptoms to watch out for include: Persistent fatigue and weakness Frequent or severe infections Unexplained bruising or bleeding (e.g., nosebleeds, bleeding gums) Fever or chills Night sweats Unexplained weight loss Swollen lymph nodes (in the neck, armpits, or groin) Pain or tenderness in the bones or joints Abdominal discomfort or swelling (due to enlarged spleen or liver) Itchy skin It's important to note that these symptoms can also be caused by many other less serious conditions. However, if you experience persistent or concerning symptoms, it's crucial to consult a doctor. Causes and Risk Factors The exact causes of most blood cancers are not fully understood. However, certain factors are known to increase the risk: Age: The risk of developing blood cancers generally increases with age. Many diagnoses occur in individuals aged 65 and older. Family History: Having a close family member (parent, sibling, or child) with a blood cancer can increase your risk. Genetic Syndromes: Certain inherited genetic conditions, such as Down syndrome, are associated with an increased risk of leukemia. Exposure to Certain Chemicals: Long-term exposure to certain industrial chemicals, like benzene, has been linked to an increased risk of leukemia. Radiation and Chemotherapy: Previous exposure to radiation therapy or certain chemotherapy drugs used to treat other cancers can increase the risk of developing a secondary blood cancer later in life. Viral Infections: Certain viral infections, such as Epstein-Barr virus (EBV) and human T-cell leukemia virus (HTLV), have been associated with some types of lymphoma and leukemia. Weakened Immune System: Conditions that weaken the immune system, such as HIV/AIDS or taking immunosuppressant drugs after an organ transplant, can increase the risk of certain lymphomas. Diagnosis of Blood Cancers Diagnosing blood cancers typically involves a combination of medical history, physical examination, and various laboratory tests: Blood Tests: Complete blood count (CBC) can reveal abnormalities in red blood cells, white blood cells, and platelets. Other blood tests can check for specific proteins or markers associated with certain blood cancers. Bone Marrow Biopsy and Aspiration: A sample of bone marrow is taken, usually from the hipbone, to examine the cells for cancerous changes. This is a key diagnostic tool for most blood cancers. Imaging Tests: CT scans, PET scans, and X-rays may be used to check for enlarged lymph nodes, spleen, or other organs, and to see if the cancer has spread. Biopsy of Lymph Nodes: If enlarged lymph nodes are found, a small sample may be removed and examined under a microscope to determine if lymphoma is present. Treatment Options Treatment for blood cancers depends on the specific type, stage, and the patient's overall health. Common treatment modalities include: Chemotherapy: The use of drugs to kill cancer cells. Radiation Therapy: Using high-energy rays to kill cancer cells. Targeted Therapy: Drugs that specifically target cancer cells' abnormalities while sparing healthy cells. Immunotherapy: Treatments that harness the patient's own immune system to fight cancer. Stem Cell Transplant (Bone Marrow Transplant): Replacing diseased bone marrow with healthy stem cells, either from the patient or a donor. Watchful Waiting: For slow-growing cancers with no symptoms, doctors may recommend closely monitoring the condition without immediate treatment. Prevention and Early Detection While not all blood cancers can be prevented, certain measures can help reduce risk and promote early detection: Maintain

In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.